✨
AI Summary
- Rick Doblin, founder of MAPS, discusses clinical research on psychedelics for treating PTSD, depression, and other conditions
- Covers the history of psychedelic research, its suppression, and current efforts to restore scientific investigation
- Explores the therapeutic potential of controlled psychedelic use in medical and psychiatric contexts
Guests on This Episode
RP
Rick Doblin: Psychedelics
1 podcast appearance